Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail.
Update: Severe Acute Respiratory Syndrome --- United States, June 4, 2003
CDC continues to work with state and local health departments, the World Health Organization (WHO), and
other partners to investigate cases of severe acute respiratory syndrome (SARS). This report updates SARS cases reported
worldwide and in the United States and summarizes changes in CDC's recommendations for travel to Singapore and Hong Kong and the resulting modification to the interim U.S. case definition for SARS.
During November 1, 2002--June 4, 2003, a total of 8,402 SARS cases were reported to WHO from 29
countries, including the United States; 772 deaths (case-fatality proportion: 9.2%) have been reported
(1). A total of 373 SARS cases identified in the United States have been reported from 41 states and Puerto Rico, with 306 (82%) cases classified as suspect SARS and 67 (18%) classified as probable SARS (i.e., more severe illnesses characterized by the presence of pneumonia
or acute respiratory distress syndrome) (2). One probable and nine suspect cases have been identified since the previous update (3). No SARS-related deaths have been
reported in the United States. Of the 67 probable cases, 65 (97%) were attributed
to international travel to areas with documented or suspected community transmission of SARS within the 10 days before
illness onset; the remaining two (3%) probable cases occurred in a health-care worker who provided care to a SARS patient and a household contact of a SARS patient. Since the previous update
(3), the number of cases with laboratory-confirmed
infection with SARS-associated coronavirus (SARS-CoV)
remains at seven; all are probable SARS cases, with no suspect SARS
cases having laboratory evidence of infection with SARS-CoV.
CDC has downgraded the traveler notification for Hong Kong from a travel advisory to a travel alert
(4,5). This change is based on surveillance data from Hong Kong indicating that the symptoms onset date of the last reported patient without a known source of exposure occurred on April 30, 2003, and that more than 20 days, or two SARS incubation periods,
have elapsed since that date. Persons who report travel to Hong Kong will continue to meet the surveillance case definition
if illness onset occurs within 10 days of travel.
The travel alert for Singapore was removed on June 4 because 30 days (three maximum incubation periods) had elapsed after the date of onset of symptoms for the last case
(6). As a result, the epidemiologic criteria for travel exposure in
the interim U.S. case definition have been revised. Illness in persons reporting travel to Singapore will be consistent with the surveillance case definition if onset occurred within 10 days (one maximum incubation period) after removal of the travel alert. This revision to the case definition is for
surveillance purposes only. Clinical judgment, rather than
surveillance criteria, should continue to guide the management of patients and implementation of public health response measures when
persons with an unknown respiratory illness are identified.
Reported by: State and local health departments. SARS Investigative Team, CDC.
CDC. Interim travel alert: Hong Kong. Available at
http://www.cdc.gov/travel/other/sarshongkong.htm.
CDC. Travel alert removal: Singapore. Available at
http://www.cdc.gov/travel/other/sarssingapore.htm.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text
into HTML. This conversion may have resulted in character translation or format errors in the HTML version.
Users should not rely on this HTML document, but are referred to the electronic PDF version and/or
the original MMWR paper copy for the official text, figures, and tables.
An original paper copy of this issue can be obtained from the Superintendent of Documents,
U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800.
Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to
mmwrq@cdc.gov.
